These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 11140660)
1. Alzheimer's disease: model behaviour. Chapman PF Nature; 2000 Dec 21-28; 408(6815):915-6. PubMed ID: 11140660 [No Abstract] [Full Text] [Related]
2. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Morgan D; Diamond DM; Gottschall PE; Ugen KE; Dickey C; Hardy J; Duff K; Jantzen P; DiCarlo G; Wilcock D; Connor K; Hatcher J; Hope C; Gordon M; Arendash GW Nature; 2000 Dec 21-28; 408(6815):982-5. PubMed ID: 11140686 [TBL] [Abstract][Full Text] [Related]
3. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Chen G; Chen KS; Knox J; Inglis J; Bernard A; Martin SJ; Justice A; McConlogue L; Games D; Freedman SB; Morris RG Nature; 2000 Dec 21-28; 408(6815):975-9. PubMed ID: 11140684 [TBL] [Abstract][Full Text] [Related]
4. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Janus C; Pearson J; McLaurin J; Mathews PM; Jiang Y; Schmidt SD; Chishti MA; Horne P; Heslin D; French J; Mount HT; Nixon RA; Mercken M; Bergeron C; Fraser PE; St George-Hyslop P; Westaway D Nature; 2000 Dec 21-28; 408(6815):979-82. PubMed ID: 11140685 [TBL] [Abstract][Full Text] [Related]
5. Repeated novel cage exposure-induced improvement of early Alzheimer's-like cognitive and amyloid changes in TASTPM mice is unrelated to changes in brain endocannabinoids levels. Pardon MC; Sarmad S; Rattray I; Bates TE; Scullion GA; Marsden CA; Barrett DA; Lowe J; Kendall DA Neurobiol Aging; 2009 Jul; 30(7):1099-113. PubMed ID: 18023506 [TBL] [Abstract][Full Text] [Related]
6. RETRACTED ARTICLE: A needle from the haystack. Morris R; Mucke L Nature; 2006 Mar; 440(7082):284-5. PubMed ID: 16541054 [No Abstract] [Full Text] [Related]
7. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Busche MA; Eichhoff G; Adelsberger H; Abramowski D; Wiederhold KH; Haass C; Staufenbiel M; Konnerth A; Garaschuk O Science; 2008 Sep; 321(5896):1686-9. PubMed ID: 18802001 [TBL] [Abstract][Full Text] [Related]
8. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease. Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931 [TBL] [Abstract][Full Text] [Related]
10. Role of apoE/Abeta interactions in Alzheimer's disease: insights from transgenic mouse models. Brendza RP; Bales KR; Paul SM; Holtzman DM Mol Psychiatry; 2002; 7(2):132-5. PubMed ID: 11840304 [No Abstract] [Full Text] [Related]
11. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities. Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686 [TBL] [Abstract][Full Text] [Related]
12. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease. Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372 [TBL] [Abstract][Full Text] [Related]
13. The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease. Schmidt AM; Sahagan B; Nelson RB; Selmer J; Rothlein R; Bell JM Curr Opin Investig Drugs; 2009 Jul; 10(7):672-80. PubMed ID: 19579173 [TBL] [Abstract][Full Text] [Related]
14. The immune system, amyloid-beta peptide, and Alzheimer's disease. Weksler ME; Gouras G; Relkin NR; Szabo P Immunol Rev; 2005 Jun; 205():244-56. PubMed ID: 15882358 [TBL] [Abstract][Full Text] [Related]
15. Alzheimer's theory makes a splash. Schnabel J Nature; 2009 May; 459(7245):310. PubMed ID: 19458681 [No Abstract] [Full Text] [Related]
16. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338 [TBL] [Abstract][Full Text] [Related]
17. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1. Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434 [TBL] [Abstract][Full Text] [Related]
18. Neuropathology: Alzheimer's in real time. Masliah E Nature; 2008 Feb; 451(7179):638-9. PubMed ID: 18256653 [No Abstract] [Full Text] [Related]
19. Decreased acetylcholine release is correlated to memory impairment in the Tg2576 transgenic mouse model of Alzheimer's disease. Watanabe T; Yamagata N; Takasaki K; Sano K; Hayakawa K; Katsurabayashi S; Egashira N; Mishima K; Iwasaki K; Fujiwara M Brain Res; 2009 Jan; 1249():222-8. PubMed ID: 18996097 [TBL] [Abstract][Full Text] [Related]
20. Modeling Alzheimer's disease and other proteopathies in vivo: is seeding the key? Walker LC; Bian F; Callahan MJ; Lipinski WJ; Durham RA; LeVine H Amino Acids; 2002; 23(1-3):87-93. PubMed ID: 12373522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]